TMDX (TransMedics Group) FFO


TMDX TransMedics Group Inc TMDX
69 GF Score
Price $77.75
GF Value $166.22
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is TransMedics Group FFO?

FFO (Funds from operations) only applies to REITs.

TMDX
69GF Score
TransMedics Group Inc TMDX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is TransMedics Group (TMDX) Overvalued in 2026?

Based on GuruFocus' analysis, TransMedics Group stock appears to be undervalued. The current stock price of $77.75 is trading 53.2% below its estimated GF Value™ of $166.22. GuruFocus considers TransMedics Group to be Possible Value Trap.

Key valuation signals for TMDX:

  • FFO:
  • GF Value™: $166.22 vs. price of $77.75 (53.2% below fair value)
  • GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the TMDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TransMedics Group Business Description

Address 200 Minuteman Road, Andover, MA, USA, 01810
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
69GF Score

Get the complete analysis for TMDX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$77.75
Price
$166.22
GF Value